Hugo Barra

"Digital health is no longer the future; it is the present, reshaping our healthcare landscape in real-time." Excited to be part of the UCSF Digital Health Hub Foundation's Quarterfinalist Party! As a past board member, I'm honored to celebrate the outstanding quarterfinalists. As we reflect on the state of digital health in 2024, it's evident that the COVID-19 pandemic has fundamentally transformed healthcare delivery. The rapid adoption of telemedicine during the crisis has become a permanent fixture, with over 60% of physicians continuing to utilize this technology. The sprint towards smarter healthcare, catalyzed by necessity, has shattered preconceptions about digital-first health experiences. Virtual care is no longer a stopgap but an integral part of a seamless, anytime, anywhere health ecosystem. 🌍 We're witnessing the rise of B2B2C models in remote consultations, with companies like Teladoc Health and Amwell partnering with insurance providers to integrate their services into health plans. Public sector collaborations, like eConsult Health 's partnership with the NHS in the #UK, underscore the potential for remote consultations to enhance efficiency and accessibility at a national level. The digital health landscape is evolving rapidly, with advancements in remote consultations, mental health support, at-home diagnostics, and patient monitoring. AI and generative AI transform care delivery, making it more efficient, personalized, and patient-centric. 🤖 Yet, challenges remain. While venture capital funding for digital health has stabilized after the pandemic boom, it remains below its 2021 peak. Sectors like digital therapeutics face reimbursement hurdles, and we've seen major players like Walmart and Optum close telehealth businesses. Looking ahead, we anticipate further consolidation in digital health, driven by acquisitions to create broader ecosystems encompass telemedicine, mental health, and other specialized services. As healthcare leaders, we must leverage these digital advancements to improve access, enhance patient outcomes, and drive efficiency in our healthcare systems. The future of healthcare is digital, and the time to embrace this transformation is now. Congratulations to all the finalists! 🎉 Looking forward to the grand finale at #HLTH2024 in #LasVegas! 🙌 By the way, the pink drink that we were holding was delicious—and nonalcoholic! The Digital Health Hub Foundation - Digital Health Awards #HealthcareInnovation #DigitalHealth #UCSFHealthHub #Networking #HealthTech #Entrepreneurship #LasVegasFinale Walter Greenleaf, PhD Daniel Kraft, MD Unity Stoakes StartUp Health University of California, San Francisco UCSF Innovation Ventures American Association for Precision Medicine (AAPM) WISE World Investors & Entrepreneurs Society #AAPMhealth #aapm_health

94

7 Comments

M13 is thrilled to lead the Series A in RadiantGraph which is focused on personalization in healthcare. As we continue to invest in early stage companies it is abundantly clear that the biggest indicator of success is the founder and his or her ability to execute on their vision of the future. In this case, I don't think I have seen much better founder-market fit than we have with founder and CEO Anmol Madan. We believe in his vision: in order to have the best patient outcomes in healthcare we need increased personalization and AI is the breakthrough to get us there. Anmol started one of the pioneering digital health companies Ginger and then was Chief Data Scientist at Livongo and Teledoc. He has done it all: early stage, late stage, public company. And he deeply understands the nuances of the healthcare market from all angles which is critical for success. While there are many players building healthcare-specific AI capabilities, RadiantGraph is focused on outcomes: The platform is already processing personalization models for more than 3.5 million people, despite launching just last year. Excited to partner with my friend Adam D'Augelli and the great True Ventures again and Morgan Blumberg who has been deep in the healthcare market with me for many years. More on our thesis in the blog below. https://lnkd.in/evDDmC3W

72

4 Comments

One of my proudest moments as an investor occurred today as Alaffia Health announced its series A because it shows how the Aperture® Venture Capital vision of multi-level, multi-generational #impactinvesting is succeeding in the marketplace. Here’s the model in its most basic form : ✅As diverse fund managers with meaningful capital to allocate, we are changing the VC landscape every day just by doing our day jobs. ✅As Black/Brown investors with ~40 years experience collectively, Aperture GPs have access to talent /excellence that others do not, so our portfolio *organically* is more inclusive by race, gender and geography even while optimizing for financial outcomes (all about the alpha). ✅Our most successful portco’s are using financial #innovation to solve market problems that impact underrepresented demographics and underserved communities. Alaffia Health is a shining example of the impact portion of our overall fund thesis, and we couldn’t be prouder of TJ Ademiluyi and Adun Akanni, MPH, PMP - the dynamic brother-sister founder duo whose vision we have steadfastly supported on their journey. Congratulations to TJ and Adun from William Crowder and myself, as well as the whole Aperture team- Marjorie King Philip McKenzie Yves Louis-Jacques Tanvi Lal Michelle Dhansinghani Lisha Bell Katie Kelly Amy Chung Cindy Chong, CFA Brian Fernandes-Halloran Monroe France Jayden Pantel Darren Herman Evan Wladis Neal Triplett Thomas Scriven Peter Ammon Irina Bit-Babik Tim Milanich Rob Rahbari

38

18 Comments

👀 Looking at our recent investments at Draper Associates, here’s what standout founders nailed, making our decision to invest much easier (and faster): 💥 Visionary Tech with a Bold Vision – These founders are not here for incremental wins; they’re reimagining what’s possible in across tech - biotech, robotics, aerospace, and beyond. Their vision is big and audacious, tackling complex problems that demand breakthrough solutions, others have not been willing to try. 👊 Clear Passion & Purpose – The drive in these founders is undeniable. They’re committed to their mission with a depth of purpose that shapes every choice. One founder, for example, took two years completely off to learn and meet everyone in longevity biotech. This level of grit and dedication is rare but essential for the most impactful founders. 🌟 Assembling All-Star Teams – They bring together top-tier talent from diverse disciplines: experienced business leaders with successful exits or industry experience at top companies, technical co-founders with deep expertise, often PhDs or industry pioneers, and even published authors. It’s a complementary team, unified by a shared vision. They make the: "Why this team?" obvious - at a glance. 💻 Data-Driven to the Core – These founders present data insights that show why their approach is unique, especially against a competitive field of companies. This data is delivered with clarity and they make the complex simple. Many are published in top journals, adding depth and credibility to their approach, and reinforcing that they know their tech inside out. ⚡️ Memorable, Clear Vision – They don’t just pitch; they make the future feel tangible, with a vision that’s both compelling and concise. If I can relay their pitch in under 30 seconds to my team, they’ve killed it. 📣 Transparent & Proactive Communication – The best founders don’t wait for questions. They come prepared, often with a comprehensive FAQ doc, give timely updates to our questions, and are candid about challenges. This level of openness builds trust and strengthens our partnership. 💸 Milestone-Driven Funding Strategy – Each funding stage aligns clearly with already achieved or upcoming achievable milestones. They’ve mapped out a roadmap that minimizes risk at every step, giving us confidence in their journey. 💰 Revenue Milestones Along the Way – Even if it'll take a decade to hit revenue on their big vision, these founders find revenue generation stops along the way to profitability. They share a trajectory that connects early wins to revenue, showing how every step is a building block toward their bigger vision. Overall, the best founders are incredibly thoughtful, prepared, and fantastic verbal / written communicators. #founders #startups #fundraising #VC

36

2 Comments

Open-source models can be a strong lever for increasing gross margins at AI companies, especially those that have hefty cost structures (e.g., enterprise sales orgs that require significant customer success or implementation resources, as well forward-deployed AI services models common in healthcare and life sciences). One of many reasons to maintain a modular and flexible stack with minimal dependencies when building an AI company. More on the importance of flexibility in the AI stack: https://lnkd.in/eA2XATRk h/t Delip Rao #ai #artificialintelligence #generativeai #healthcare

50

6 Comments

mdhub (YC S24) is a clinical AI assistant for mental health clinicians, helping them run their clinics more efficiently. Mental health issues are a growing concern in America, with approximately 50 million Americans currently grappling with a mental health condition— a number increasing by 1.5 million every year. At the same time, the US is experiencing a massive shortage of 30,000 mental health clinicians in 2024, a situation costing the US health system $300 billion annually due to delayed treatment. Yet, clinicians are spending only 50% of their day with patients, while the rest of their time is consumed by admin-heavy work, delaying access to mental health care even further. With mdhub, mental health clinicians become 10x more efficient by automating tasks such as clinical documentation, drafting patient after-visit reports, pre-charting, and treatment planning. Over the last 6 months, mdhub has already successfully saved clinicians more than 100,000 hours in admin tasks. Congrats on the launch, Efrén A. Lamolda and Dominik Middelmann! 🚀 https://lnkd.in/gPCTzfy9

90

5 Comments

I'm so excited to continue supporting Prolific Machines, Inc., and the incredible Deniz Kent, PhD ,Max Huisman, and Declan Jones. Today's cellular biology processes are incredibly expensive, inefficient, imprecise, and sometimes purely ineffective. These processes are used from everything from making antibodies to treat diseases, to fermentation used to make high-value nutritional proteins in baby formula, to whole cuts of cultured meat. Prolific has developed a biology platform that leverages light to guide cell behavior and optimize performance over time using AI. By combining light, bioengineering, hardware, and AI in fundamentally new ways, Prolific can help pharmaceutical, nutritional, and therapeutics companies get to market faster, less expensively, and more efficiently — ultimately in hopes of helping improve outcomes — a mission any of us can get behind. Mark Cuban Peter T. Frederick Blackford Cooper Rinzler David Adelman Darco Capital Breakthrough Energy Michael Schulson Kevin Love Tobias Harris Breyer Capital Charles Besser Brennan Besser Lettuce Entertain You Restaurants https://lnkd.in/ea2TqdQk

159

17 Comments

Proud to be partnering with Sara Beykpour, Marcel Molina, and the Particle team as we announce today that Lightspeed is leading the $10.9M Series A financing! Particle's founding team helped build some of the internet's most innovative consumer products, including Twitter, Vine, Periscope, and Secret. At Twitter, they discovered the power of LLMs and became determined to reinvent news and media using these new AI superpowers 🦸 AI is reorganizing the way media is both created and consumed on the internet. Particle’s initial content focus is news – a category that is increasingly broken due to misaligned incentives between publishers and readers. But we believe AI can help to maximize value for both… 🗞️ The vision for Particle is to become the go-to destination people visit to be quickly yet deeply educated about any topic or story – with a highly personalized, efficient, and interactive experience, powered by amazing journalists ✍️ Michael Mignano & I are excited to be on this journey with the Particle team –and we can't wait to have you onboard as well! Head over and join the waitlist now ahead of our official launch ⬇️ particle.news

127

6 Comments

This is just incredible. Neal Ghosh's demonstration of how #VentureIQ takes deeply technical and complicated content across a range of industrial use cases and ages/stages through an AI-generated conversational podcast (a la #notebookLM) is really mind-blowing. Check out his post, below, and if you haven't seen VentureIQ, yet, let's get you set up to learn more. You can visit VentureIQ.ai or DM any of us over here to book a demo!

2

I’m thrilled to be announcing that Notion Capital is leading the $15m Series A investment in Cogna today. In the industry, we like to think that software has been eating the world. But when you look at the data a better description would be more of a nibble. Depending on what source you look at the software industry represents between 5-8% of global GDP. Contrast that with the services industry that represents between 60-70% of GDP and worth around $25 trillion on a global basis. Most services have been out of reach for the software industry. They have either been too complex or too specialized for off the shelf software to access in any economically viable way. But that’s beginnning to change with GenAI leading to the emergence of ‘service as a software.’ Cogna is at the forefront of this opportunity - building precision software at scale and delivering huge productivity gains for traditional industries. We know Ben Peters & Lars Mennen well having backed their previous company Five AI that was acquired by Bosch in 2022. And we’re very excited to be backing them again together with Hoxton Ventures & Chalfen Ventures Read my full blog post on why we invested here. Radu Bozga Ben Peters Lars Mennen Bryan G. Mike Chalfen Hussein Kanji Kirsten Connell https://lnkd.in/eh8mhcJb

201

13 Comments

Hot off the pre-print server – an important publication authored by the Atropos Health team exploring the performance of LLMs in answering real-world clinical questions. LLMs excel at summarizing and contextualizing existing literature, but cannot generate de novo medical evidence today. The results of the study highlight performance gains attributable to injecting novel, relevant, and up-to-date medical evidence into LLM-powered clinical decision support systems. Brigham Hyde Nigam Shah Saurabh Gombar Read the study here: https://lnkd.in/ecuU25Pq

49

2 Comments

Today marks a groundbreaking moment for BLCK VC and our fellow collaborators—Diversity VC, All Raise, 2Gether-International, SomosVC, StartOut, and VetsinTech—as we proudly announce the launch of the Diversity Data Alliance. This important alliance underscores our unwavering commitment to nurturing a venture capital and entrepreneurial ecosystem abundant in equity and inclusiveness. By standardizing and linking our data, we empower ourselves with the essential tools to track deeper trends that have, until now, eluded us to identify and fill funding gaps for historically excluded investors, founders, and operators. We can’t change what we do not measure, and now with the Diversity Data Alliance, we're now equipped to do both. Join us in this mission. Learn more and get involved: https://lnkd.in/eEZKdrac #DiversityDataAlliance #BLCKVC #VentureCapital #MeasureToChange

112

1 Comment

Platforms are in, point solutions are out as the healthcare AI category leaders come into focus this year. In conversation with Shelby Livingston at Endpoints News, I shared: 1. Why AI-first companies have the greatest platform potential and heuristics for identifying these opportunities at the earliest stages, 2. How companies are differentiating through co-development and distribution partnerships with leading healthcare institutions, and 3. Strategies for navigating anemic budgets and constrained market sizes through business model innovation such as AI-enabled services and pay for performance models Read more here: https://lnkd.in/dJWqv_zC Bessemer Venture Partners Abridge #healthcare #lifesciences #AI #generativeAI

258

14 Comments

Proud to have supported Wander in securing their recent $1M extension seed round! 🚀 This achievement underscores a crucial lesson in startup growth: success in follow-on funding rounds demands strategic thinking and unwavering dedication to hitting key milestones. Wander's team, led by the visionary AJ Brau, has exemplified this perfectly. Their journey from concept to a global, AI-enhanced interactive mapping platform is a testament to the power of customer-centric innovation and persistent execution. It's been a privilege to guide them through our Value Creation program, helping translate potential into a robust, actionable strategy. To aspiring entrepreneurs: remember, each funding round presents unique challenges. While initial rounds often focus on your idea, vision, and promises, follow-on rounds require solid achievements and compelling arguments supporting your actual execution. Key points to consider: 1. Expect your initial plan to evolve; investors understand that perfect 1:1 execution is rare. 2. Be prepared to showcase your decision-making process and how you've adapted to challenges. 3. Governance and operational mechanics will be scrutinized more closely in later rounds. 4. Focus on creating tangible value, hitting your targets, and effectively communicating your progress and learnings. Remember, each round is an opportunity to prove your ability to execute and adapt. The capital will follow well-executed strategies and demonstrated results. Congratulations to AJ and the entire Wander team! Your hard work is paying off, and I'm excited to see where this new funding takes you. Read more about Wander's journey and innovative approach here: https://lnkd.in/dE-9n8_2 #StartupSuccess #VentureCapital #TravelTech #Innovation #ValueCreation #Utah #Advisor

23

6 Comments

What do bio and health applications mean for the next wave of AI -- specifically about compute? (I'm talking to you NVDA longs!) LifeX Ventures is hosting a super roundtable with some serious techbio leaders tomorrow along with Analog Century Management's Val Zlatev -- come hear Thomas Clozel Sean McClain Chetan Patel at 11am ET For the survey results based on asking 100 techbio CTOs and CEOs, join the call. Here, my own speculations after wrapping up the report: -- Amazon needs to have a GPU program on warp drive right now -- Nvidia needs to have a data center / cloud business in the works -- Edge AI chips are about to be everywhere -- in your watch, car, sneakers, thermostats, gene sequencers, spectroscopes -- All this compute needs way more data: expect a boom in sensors of all types -- Remember human genome moonshot that sequenced one person once? Now you can sequence your every cell one by one. Expect that for protein folding (AlphaFold was that moonshot) and other simulation uses, a full "twin" model of you, cell by cell -- Google has no angle here -- worse chips, worse cloud, worse models, worse phones / edge devices -- Specialty silicon for unique use-cases, lower-power, lower-memory are surely coming fast - like back in the day for mobile phones when Qualcomm, Broadcomm, Infineon, Mediatek, etc duked it out.

26

5 Comments

Looking beyond #VC funding for your #startup? Aakash Shah of Wyndly (YC W21) reveals how he built a multi-million dollar #healthtech company using creative capital strategies. Learn how he leveraged Y Combinator's network and alternative funding methods to revolutionize allergy treatment. In case you missed it, you can watch the #FundraisingDemystified #podcast here: https://lnkd.in/eZT63YS4

5

2 Comments

🔥 Thrilled to see Hydrolix crushing it with a $35M Series B! 🔥 Data is the new oil, but too much gets discarded due to prohibitive storage costs. Hydrolix cracks this with its streaming #datalake platform that leverages object storage, decoupled compute, indexing, & compression. As Marty Kagan puts it: 'We’re cheaper than cold storage and faster than hot storage' Hydrolix’s streaming data lake platform is a game-changer for #AI, #observability, & #security workloads. 💥 Real-time query performance at terabyte scale 💰75%+ savings on log mgmt & 4x more data retained  ☁️ Stateless & containerized for seamless scaling with Amazon Web Services (AWS) S3, Google Cloud GCS, Microsoft Azure Blob 💡 Had the early conviction (first investor) that data is key to unlocking AI & enterprise workloads. It's proving right. Huge thanks to Marty Kagan Hasan Alayli for letting me early on their journey to build an impessive company 🙏 Super pumped to have awesome Aaron Perman at S3 Ventures leading this round along with other strong existing investors - Nava Ventures (Manish Patel) Wing Venture Capital (Peter Wagner) Oregon Venture Fund (Matt Compton Scott Grout) and others 💪 Onwards! 🚀🚀🚀 #cloud #data #ai #ml #llm #largelanguagemodels #analytics #security #loganalytics #datalake #datawarehouse https://lnkd.in/g5i6afP5

42

7 Comments

Boston's vibrant health tech scene is fueled by world-class accelerators and incubators, empowering startups to drive digital health, biotech, and life sciences breakthroughs. Here’s a look at some key players: MassChallenge HealthTech—This accelerator helps startups transform health solutions across digital and biotech. It connects entrepreneurs with resources and mentors to drive meaningful change. LabCentral – A coworking lab space offering shared resources and lab facilities, LabCentral supports biotech and health tech startups by providing them with an innovative, collaborative environment. #Pagliuca Harvard Life Lab – Located at Harvard, this incubator offers lab and office space to promising biotech and life sciences startups, helping them scale groundbreaking health tech solutions. Richi Entrepreneurs – With a global outlook, Richi Entrepreneurs offers a unique two-week immersion for international health tech startups, connecting them with Boston’s local mentors, investors, and industry leaders. Xontogeny – Specializing in life sciences, Xontogeny partners with early-stage health tech companies, providing strategic guidance and operational support to accelerate their journey from concept to market. These incubators and accelerators are not just nurturing innovation—they’re powering the next generation of health solutions! 🌟 #BostonHealthTech #InnovationEcosystem #Biotech #HealthTech #StartupAccelerators

17

The most talked about AI x Medical startup Abridge is working to rescue doctors from the never-ending admin grind (which causes burnout and less patient face-time). Abridge's AI listens to patient visits and generates precise medical notes, slashing the clerical workload. Now, doctors can focus on what truly matters: patient care. Major health systems like Yale and Emory are already on board and raving, calling it "life-changing" and "magical." 🔷 A big reason --> Payback of the scribe tool is easy to measure. It supports 14 languages including Haitian Creole, Brazilian Portuguese, and Punjabi. An ongoing criticism of generative AI is that it still has few substantive business applications. This seems to quash that. Question: is a dedicated medical LLM needed to be successful in the space? Or will the huge foundational models (GPT-4o, Google, and Meta) ingest a plethora of medical notes and kill the competition with performance? We're dealing with a fast and furious pace, and today's edge may not be relevant tomorrow. Competitors include Microsoft-owned Nuance Healthcare , Ambience Healthcare, Nabla and Suki. I'm excited to continue to see this field revolutionized. 🌟 #AI #MedTech #Abridge #HealthTech

12

5 Comments